Target intelligence / Profile preview

Latrotoxin

Molecular classification
Other (venom-derived neurotoxin protein family), Pore-forming toxin
01

Overview

Latrotoxin refers to a family of large, presynaptic, pore-forming neurotoxin proteins found in the venom of Latrodectus (black widow) spiders[1][3][4][5]. This protein family (including α-latrotoxin, β-latroinsectotoxin, γ-latroinsectotoxin, δ-latroinsectotoxin, ε-latroinsectotoxin, and α-latrocrustatoxin) targets specific nervous system receptors in animal prey. The best studied member, α-latrotoxin, is vertebrate-specific and causes the clinical syndrome latrodectism in humans. Latrotoxins bind specific neuronal receptors—primarily neurexins, latrophilins, and protein tyrosine phosphatase σ—oligomerize, and assemble into tetrameric pores in the cell membrane. This leads to a massive, uncontrolled release of neurotransmitters by permitting Ca²⁺ influx, ultimately resulting in severe neurotoxic symptoms. Though of high scientific interest as molecular probes and for their unique mechanism, latrotoxins as a group are not considered therapeutic targets; rather, they are the molecular agents of the spider’s toxic effects[1][3][4][5]. “Latrodectus venom toxin” is not a precise canonical molecular or receptor name but rather refers collectively to multiple related proteins—each with specific targets and activities. The correct molecular targets (e.g., α-latrotoxin) should be specified for precise scientific or drug discovery work[1][3][4][5].

Other names
Latrodectus venom toxinLatrotoxinsLTXs
02

Mechanism of action

Binds specific neuronal receptors (e.g., neurexins, latrophilins, PTPσ) and inserts into membranes as a tetramer, forming Ca²⁺-permeable pores that trigger uncontrolled neurotransmitter release[1][3][5]. Receptor activation leading to intracellular signaling causing exocytosis[5].

03

Biological functions

Neurotransmitter release (by stimulating exocytosis)Pore formation in neuronal cell membranesInduction of calcium influx
04

Disease associations

Other (cause of latrodectism, severe envenomation syndrome)Other (toxin-related neurotoxicity in animals and humans)
05

Safety considerations

Severe neurotoxic effects: muscle cramps, hypertension, sweating, vomiting, painToxicity associated with massive neurotransmitter release (e.g., catecholamines)[6]Risk of systemic envenomation following spider bite
06

Interacting drugs

Antivenom for Latrodectus venom

Beyond the preview

Go deeper on Latrotoxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Latrotoxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call